reviewTop 1% cited

Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis

Atherosclerosis · 2017 · Vol. 259 · pp. 75–82

Yunwei Li(Henan University Huaihe Hospital and Huaihe Clinical Institute)Xiaoming Zhong(Henan University Huaihe Hospital and Huaihe Clinical Institute)Guanchang Cheng✉(Henan University Huaihe Hospital and Huaihe Clinical Institute)Cui‐Hua Zhao(Henan University Huaihe Hospital and Huaihe Clinical Institute)Lei Zhang(Henan University Huaihe Hospital and Huaihe Clinical Institute)Hong Yan(Henan University Huaihe Hospital and Huaihe Clinical Institute)Qilin Wan(Henan University Huaihe Hospital and Huaihe Clinical Institute)Ruili He(Henan University Huaihe Hospital and Huaihe Clinical Institute)Zhizhong Wang(Henan University Huaihe Hospital and Huaihe Clinical Institute)

View via DOI Publisher page

Adipokines, Inflammation, and Metabolic Diseases Inflammatory Biomarkers in Disease Prognosis COVID-19 Clinical Research StudiesMedicineInternal medicineConfidence intervalRelative riskMeta-analysisPopulationCancerC-reactive proteinRisk of mortalityProspective cohort study

MeSH terms

AdultAgedAged, 80 and overC-Reactive ProteinCardiovascular DiseasesCause of DeathHumansMiddle AgedNeoplasmsPredictive Value of TestsPrognosisRisk FactorsSex FactorsBiomarkersUp-Regulation

Citations

426

FWCI

21.57

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study